FDA Seeks Fines for Unauthorized Tobacco Sales from Retailers

Sep.24.2024

FDA seeks fines from 11 retailers for unauthorized tobacco sales, warning letters ignored, total penalty $20,678 each.

On September 23, the US Food and Drug Administration (FDA) announced that it is seeking fines against two physical retail establishments and nine online retailers. The FDA had previously issued warning letters to these retailers for selling unauthorized tobacco products, but follow-up inspections found that they had not corrected their violations. Therefore, the FDA is now seeking civil fines of $20,678 from each retailer.

So far, the FDA has filed civil penalty lawsuits against 70 manufacturers and 160 retailers, accusing them of distributing or selling unauthorized tobacco products.

References:

[1] FDA Seeks Civil Money Penalties Against 11 Retailers Selling Unauthorized E-Cigarettes

Also Read:

[1] Advancing Smoking Cessation: FDA and NIH Priorities

[2] US House Committee Questions FDA's Focus on E-cigarette Regulation

[3] U.S. FDA Youth Survey: ELFBAR Usage Drops to 36% After FDA Enforcement, ZYN Becomes Top Choice Among Teens

[4] FDA Proposed Rule Requires Importers to Submit STN for ENDS

[5] Study on the Impact of Public Health Communication on Tobacco

[6] U.S. Appeals Court Overturns FDA's E-cigarette Marketing Denial Order

#Law enforcement #North America #United States #Traditional tobacco

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.